Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment.
about
Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated HepatocarcinogenesisTurning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsConfirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-DistanceRewriting the epigenetic code for tumor resensitization: a review.Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapiesThe war on cancer: a military perspectiveRRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities.RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum DoubletsPartial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC.Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets.An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder CancerA novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells.MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.Entinostat for the treatment of breast cancer.Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet.
P2860
Q26739018-8E7392B2-DD81-4C32-A5D7-5D674844338CQ26744212-861DF5B4-5689-4388-94E4-671973FAD38BQ26782138-0E9DF43A-3622-4228-872D-36FFE2A3652AQ27687583-A3D3C9DB-357C-412A-BFBC-9A06D60E87DFQ28074716-3C5DF5D9-599D-4C21-BBEB-12F127A8ED80Q28083060-815D7999-655F-442D-8109-EB359CD217D8Q30010522-F2855947-7728-4749-B315-9CCB353129D6Q35640652-C0B35865-9F94-43B2-9D87-073C371CF6FAQ36766225-EE69F5E5-204F-42CB-AF25-4C2E30C6A9F0Q37019034-0373FD2A-3F0A-49B2-A164-8CFDB5E6C072Q37045774-7525A423-3BA3-4A6E-B259-F1889A27816EQ37290684-C5ABBCF7-D88F-44CB-B940-13E6F7B3BFDDQ37389377-5A105FF3-AC0E-4A3C-BE6A-9FE3D1A82E66Q37437269-F0B793CB-9083-434F-921E-C96DF374CFABQ38674317-06EFC39B-058E-432E-ABF1-5D788EA789F0Q38843175-4336E3F5-5CF0-478C-AA19-51FB696C5607Q41194522-DE70D7E4-82B4-40F0-8F3E-459F34D42C8CQ45973958-E8FE03B0-51A6-4E52-AA41-10F7A2586836Q46237277-FE4B29E6-203F-4B24-9AC2-DEBDFEEB8956Q47199869-08577D08-A0CE-4F85-96D7-6E1658BD0129Q47960118-6D66D161-8146-407E-A7CF-9F53546207F0Q52649451-A86FF855-DFCC-4612-8190-D412DE81C394
P2860
Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Episensitization: therapeutic ...... ts: a review and reassessment.
@ast
Episensitization: therapeutic ...... ts: a review and reassessment.
@en
Episensitization: therapeutic ...... ts: a review and reassessment.
@nl
type
label
Episensitization: therapeutic ...... ts: a review and reassessment.
@ast
Episensitization: therapeutic ...... ts: a review and reassessment.
@en
Episensitization: therapeutic ...... ts: a review and reassessment.
@nl
prefLabel
Episensitization: therapeutic ...... ts: a review and reassessment.
@ast
Episensitization: therapeutic ...... ts: a review and reassessment.
@en
Episensitization: therapeutic ...... ts: a review and reassessment.
@nl
P2093
P2860
P921
P1476
Episensitization: therapeutic ...... nts: a review and reassessment
@en
P2093
Bryan Oronsky
Gary Fanger
Neil Oronsky
Susan Knox
P2860
P304
P356
10.2174/1871520614666140418144610
P5008
P577
2014-01-01T00:00:00Z